The single-cell multi-omics measures the multiple types of the molecule from the single cell of the same individual. The multi-omics enables the data from the various omics platforms. The multi-omics insight into inter-relation of the omics layers on the process of the diseases. The single-cell sequencing technology divided into genotypic and phenotypic which helps to determine the mechanisms to govern the diseases and health.Single-Cell Multi-Omics Market was valued at US$ 2.9 billion in 2024 and is projected to grow at a CAGR of 14.8% to reach US$ 11.5 billion by 2034.

The report "Single-Cell Multi-Omics Market, By Type (Single Cell Genomics, Single Cell Transcriptomics and Proteomics, and Single Cell Metabolomics), By Product (Instruments and Consumables), By Workflow (Single Cell Isolation, Single Cell Preparation, and Single Cell Analysis), By Application (Oncology, Immunology, Neurology, Microbiology, Stem Cell, Cell Biology, and Others), By End-User (Research and Academic Laboratories, Biopharmaceutical and Biotech Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Highlights:

• Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the product to gain a competitive edge in the target market. For instance, 10X Genomics Inc. acquired the Spatial Transcriptomics to increase the product portfolio in the sector of transcriptomics analysis, in 2018.  

Analyst View:

The advancement and development in the next-generation sequencing technique for the diagnosis of oncology, immunology, and other is the major propelling factor for the growth of the global single-cell multi-omics market. According to the World Health Organization (WHO), effective and timely treatment of ID can both raise national productivity levels by as much as 20% and also rise in restore personal health. Moreover, non-invasive diagnosis is advance technology, it overcomes the challenge of heterogeneity associated with bulk cell populations that increases the need for non- invasive diagnosis is the propelling factor for the growth of the target market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Single-Cell Multi-Omics Market, By Type (Single Cell Genomics, Single Cell Transcriptomics and Proteomics, and Single Cell Metabolomics), By Product (Instruments and Consumables), By Workflow (Single Cell Isolation, Single Cell Preparation, and Single Cell Analysis), By Application (Oncology, Immunology, Neurology, Microbiology, Stem Cell, Cell Biology, and Others), By End-User (Research and Academic Laboratories, Biopharmaceutical and Biotech Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Single-Cell Multi-Omics Market was valued at US$ 2.9 billion in 2024 and is projected to grow at a CAGR of 14.8% to reach US$ 11.5 billion by 2034.The single-cell multi-omics market is segmented based on type, product, workflow, end-user, and region.

• Based on type, the single-cell multi-omics market is segmented into single-cell genomics, single-cell transcriptomics and proteomics, and single-cell metabolomics.
• Based on the product, the target market is segmented into instruments and consumables.
• Based on workflow, the global market is classified into single-cell isolation, single-cell preparation, and single-cell analysis
• Based on the application, the target market is divided into oncology, immunology, neurology, microbiology, stem cell, cell biology, and others.
• Based on the region the single-cell multi-omics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global single-cell multi-omics market due to the increase in adoption of the single-cell technology which is driven by various government initiatives. In the European region single-cell, the multi-omics market is projected to register a high CAGR over the forecast period due to increasing healthcare system and its infrastructure.

Competitive Landscape:

The key players operating the single-cell multi-omics market involves 1CellBio, 10X Genomics Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., Spatial Transcriptomics, Fluidigm Corporation, Fluxion Biosciences, NanoString Technologies, Inc., and Illumina, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com